Abuse and toxicity of methylphenidate
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The therapeutic use of methylphenidate for the management of attention-deficit hyperactivity disorder in children is increasing. As therapeutic use increases, the risk increases of unintentional overdoses, medication errors, and intentional overdoses caused by abuse, misuse, or suicide gestures and attempts. Side effects during therapy, which include nervousness, headache, insomnia, anorexia, and tachycardia, increase linearly with dose. Clinical manifestations of overdoses include agitation, hallucinations, psychosis, lethargy, seizures, tachycardia, dysrhythmias, hypertension, and hyperthermia. Methylphenidate tablets can be abused orally, or they can be crushed and the powder injected or snorted. Despite its abuse potential, there is disagreement regarding the extent to which methylphenidate is being diverted from legitimate use to abuse in preteens and adolescents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
Trends in the Prescribing of Psychotropic Medications to Preschoolers
Zito, J. M. (2000) · JAMA · doi:10.1001/jama.283.8.1025 · Cited by 863
Volkow, N. D. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950180042006 · Cited by 575
BIEDERMAN, J., WILENS, T., MICK, E., FARAONE, S. V., WEBER, W., CURTIS, S., THORNELL, A., PFISTER, K., JETTON, J. G., & SORIANO, J. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199701000-00013 · Cited by 476
Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?
SPENCER, T. J., BIEDERMAN, J., HARDING, M., O'DONNELL, D., FARAONE, S. V., & WILENS, T. E. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199611000-00014 · Cited by 238
Cited by
Styne, D. M., Arslanian, S. A., Connor, E. L., Farooqi, I. S., Murad, M. H., Silverstein, J. H., & Yanovski, J. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2573 · Cited by 1,282
Bolaños, C. A., Barrot, M., Berton, O., Wallace-Black, D., & Nestler, E. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00570-5 · Cited by 268
Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies
Linssen, A. M. W., Sambeth, A., Vuurman, E. F. P. M., & Riedel, W. J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001594 · Cited by 159
“, 2004), which explains why people who use MPH to induce a high administer it intravenously or intranasally, while people who merely take it to stay awake, take it orally (Klein-Schwartz, 2002; Volkow and Swanson, 2003).”
BackgroundMosholder, A. D., Gelperin, K., Hammad, T. A., Phelan, K., & Johann-Liang, R. (2009) · Pediatrics · doi:10.1542/peds.2008-0185 · Cited by 155
Substance Abuse in Patients with Attention-Deficit Hyperactivity Disorder: Therapeutic Implications
Schubiner, H. (2005) · CNS Drugs · doi:10.2165/00023210-200519080-00001 · Cited by 104
Metadata
- Authors
- Klein-Schwartz, W.
- Venue
- Current Opinion in Pediatrics
- Published
- 2002-04
- Volume
- 14
- Issue
- 2
- Pages
- 219-223
- ISSN
- 1040-8703 (ISSN-L)
- OpenAlex
- W2051791048
- Cited by
- 168
- References
- 5
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Abuse and toxicity of methylphenidate. https://app.cochat.ai/papers/10.1097/00008480-200204000-00013
- The paper
- Klein-Schwartz, W. (2002). Abuse and toxicity of methylphenidate. Current Opinion in Pediatrics. https://doi.org/10.1097/00008480-200204000-00013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.